Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2025-12-24 @ 5:17 PM
NCT ID:
NCT02595450
Eligibility Criteria:
Inclusion Criteria:
* It is the physician's decision to prescribe erlotinib in participants and to document their treatment
* Participants must be candidates for receiving erlotinib for locally advanced or metastatic non-small cell lung cancer according to the product label
Exclusion Criteria:
* Participants will be excluded if safety concerns occurred
* If the participant was not compliant or if the participant would wish to stop erlotinib therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
35 Years
Maximum Age:
86 Years
Study:
NCT02595450
Study Brief:
Protocol Section:
NCT02595450